1,042
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Changes in self-reported risky sexual behaviour indicators among adults receiving regular risk reduction counselling and optional initiation of pre-exposure prophylaxis in an HIV vaccine preparedness study in Masaka, Uganda

ORCID Icon, , , , , , , & show all
Article: 2242672 | Received 20 Mar 2023, Accepted 27 Jul 2023, Published online: 07 Aug 2023

References

  • UNAIDS. Global HIV & AIDS statistics—2022 fact sheet. 2022.
  • World Health Organisation. HIV prevention, diagnosis, treatment, and care for key populations. Geneva: World Health Organisation; 2016.
  • Uganda AIDS Commission. Factsheet - facts on HIV and AIDS in Uganda 2021 (based on data ending 31st December 2020). 2021.
  • AVERT. Key affected populations, HIV and AIDS 2017. [cited 2023 Jan 20]. Available from: https://www.avert.org/professional/hiv-social-issues/key-affected-populations
  • Lauren Gooden LRM, Feaster DJ. Examining the efficacy of HIV risk-reduction counselling on the sexual risk behaviors of a national sample of drug abuse treatment clients: analysis of subgroups. AIDS Behav. 2017;20:1893–10. doi: 10.1007/s10461-016-1300-6
  • George G, Beckett S, Cawood C, Khanyile D, Govender K, Kharsany ABM. Impact of HIV testing and treatment services on risky sexual behaviour in the uMgungundlovu district, KwaZulu-Natal, South Africa: a cross-sectional study. AIDS Res Ther. 2019;16:20. doi: 10.1186/s12981-019-0237-z
  • Zajac K, Kennedy CE, Fonner VA, Armstrong KS, O’Reilly KR, Sweat MD. A systematic review of the effects of behavioral counseling on sexual risk behaviors and HIV/STI prevalence in low- and middle-income countries. AIDS & Behav. 2015;19:1178–1202. doi: 10.1007/s10461-014-0893-x PubMed PMID: 25213302.
  • Jill Blumenthal RH. Risk compensation in PrEP: an old debate emerges yet again. Virtual Mentor. 2014;16:909–915.
  • Hogben M, Liddon N. Disinhibition and risk compensation: scope, definitions, and perspective. Sex Transm Dis. 2008;35:1009–1010. doi: 10.1097/OLQ.0b013e31818eb752 Epub 2008/10/22. PubMed PMID: 18936724.
  • Riess TH, Achieng’ MM, Otieno S, Ndinya-Achola JO, Bailey RC, Myer L. “When I was circumcised I was taught certain things”: risk compensation and protective sexual behavior among circumcised men in Kisumu, Kenya. PLoS One. 2010;5:e12366. doi: 10.1371/journal.pone.0012366
  • Yan X, Jia Z, Zhang B. Evaluating the risk compensation of HIV/AIDS prevention measures. Lancet Infect Dis. 2022;22:447–448. doi: 10.1016/S1473-3099(22)00151-7
  • Zheng Y, Yu Q, Lin Y, Zhou Y, Lan L, Yang S, et al. Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. Lancet Infect Dis. 2022;22:541–551. doi: 10.1016/S1473-3099(21)00448-5
  • PREPVACC. Registration cohort. [cited 2021 Dec 11]. Available from: https://www.prepvacc.org/registration-cohort.
  • Kusemererwa S, Kansiime S, Mutonyi G, Namirembe A, Katana S, Kitonsa J, et al. Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda. Medicine (Baltimore). 2021;100:e27719–e. doi: 10.1097/MD.0000000000027719 PubMed PMID: 34871265.
  • Ministry of Health Uganda. National implementation guidelines for HIV counselling and testing in Uganda. Ministry of Health; 2010.
  • Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1–17. quiz CE1-4. Epub 2006/09/22. PubMed PMID: 16988643.
  • Guest G, Shattuck D, Johnson L, Akumatey B, Clarke EE, Chen PL, et al. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial. Sex Transm Dis. 2008;35:1002–1008. doi: 10.1097/OLQ.0b013e3181812939 Epub 2008/12/04. PubMed PMID: 19051397.
  • Bolu OO, Lindsey C, Kamb ML, Kent C, Zenilman J, Douglas JMJ, et al. Is HIV/sexually transmitted disease prevention counseling effective among vulnerable populations? A subset analysis of data collected for a randomized, controlled trial evaluating counseling efficacy (Project RESPECT). Sex Transm Dis. 2004;31:469–474. doi: 10.1097/01.olq.0000135987.12346.f2 PubMed PMID: 00007435-200408000-00005.
  • Xu J-J, Zhang C, Hu Q-H, Chu Z-X, Zhang J, Li Y-Z, et al. Recreational drug use and risks of HIV and sexually transmitted infections among Chinese men who have sex with men: mediation through multiple sexual partnerships. BMC Infect Dis. 2014;14:642–. doi: 10.1186/s12879-014-0642-9 PubMed PMID: 25443542.
  • Garin N, Velasco C, De Pourcq J, Lopez B, Gutierrez M, Haro J, et al. Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations. Front Microbiol. 2015;6: doi: 10.3389/fmicb.2015.00690
  • Myer L, Mathews C, Little F. Improving the accessibility of condoms in South Africa: the role of informal distribution. AIDS Care. 2002;14:773–778. doi: 10.1080/0954012021000031840 Epub 2003/01/04. PubMed PMID: 12511210.
  • Analogbei T, Dear N, Reed D, Esber A, Akintunde A, Bahemana E, et al. Predictors and barriers to condom use in the African cohort study. AIDS Patient Care STDS. 2020;34:228–236. doi: 10.1089/apc.2019.0302 Epub 2020/05/13. PubMed PMID: 32396478.
  • Maharajh R, Haffejee F. Exploring male condom use among women in South Africa: a review of the literature. Afr J AIDS Res. 2021;20:6–14. doi: 10.2989/16085906.2021.1872663 Epub 2021/03/10. PubMed PMID: 33685378.
  • Donnenfeld Z What is driving sub-Saharan Africa’s rapid rise in drug use? 2019. [cited 2023 Jan 30]. Available from: https://issafrica.org/iss-today/what-is-driving-sub-saharan-africas-rapid-rise-in-drug-use
  • Ssuna B, Katahoire A, Armstrong-Hough M, Kalibbala D, Kalyango JN, Kiweewa FM. Factors associated with willingness to use oral pre-exposure prophylaxis (PrEP) in a fisher-folk community in peri-urban Kampala, Uganda. BMC Public Health. 2022;22:468. doi: 10.1186/s12889-022-12859-w
  • Kusemererwa S, Kansiime S, Mutonyi G, Namirembe A, Katana S, Kitonsa J, et al. Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda. Medicine. 2021;100:e27719. doi: 10.1097/md.0000000000027719 PubMed PMID: 00005792-202111050-00064.
  • Neil Andersson AC, Cockcroft A. Male circumcision, attitudes to HIV prevention and HIV status: a cross-sectional study in Botswana, Namibia and Swaziland. AIDS Care. 2011;24:301–309. doi: 10.1080/09540121.2011.608793
  • Eaton SK LA, Kalichman SC. Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies. Current HIV/AIDS Reports. 2007;4:165–172. doi: 10.1007/s11904-007-0024-7
  • Kim HB, Kim B, Pop-Eleches C, Jung J. Male circumcision, peer effects, and risk compensation. 2021. [cited 2023 Feb 1]. Available from: http://www.columbia.edu/~cp2124/papers/MC_Risk_Compensation.pdf
  • Shi CF, Li M, Dushoff J, Price MA. Evidence that promotion of male circumcision did not lead to sexual risk compensation in prioritized sub-Saharan countries. PLoS One. 2017;12:e0175928. doi: 10.1371/journal.pone.0175928 Epub 2017/04/26. PubMed PMID: 28441458; PubMed Central PMCID: PMCPMC5404849.
  • Peterson L, Taylor D, Roddy R, Belai G, Phillips P, Nanda K, et al. Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials. 2007;2:e27. doi: 10.1371/journal.pctr.0020027 Epub 2007/05/26.
  • Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423–434. doi: 10.1056/NEJMoa1110711 Epub 2012/07/13. PubMed PMID: 22784038.
  • Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399–410. doi: 10.1056/NEJMoa1108524 Epub 2012/07/13. PubMed PMID: 22784037; PubMed Central PMCID: PMCPMC3770474.
  • Kitonsa J, Kamacooko O, Bahemuka UM, Kibengo F, Kakande A, Wajja A, et al. Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda. PLoS One. 2021;16:e0251992. doi: 10.1371/journal.pone.0251992
  • Ruzagira E, Wandiembe S, Bufumbo L, Levin J, Price MA, Grosskurth H, et al. Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda. Trop Med Int Health. 2009;14:196–203. doi: 10.1111/j.1365-3156.2008.02200.x
  • Kim Ashburn J, Kalibala S, Kimani V, Ngugi E, Nyblade L, OlenJa J, et al. Clinical science meets social science: gender and AIDS vaccine research 2008. [cited 2023 Feb 2]. Available from https://www.iavi.org/phocadownload/IAVI_Clinical%20Science%20Meets%20Social%20Science%20Gender%20and%20AIDS%20Vaccine%20Research.pdf.
  • Kabarambi A, Kansiime S, Kusemererwa S, Kitonsa J, Kaleebu P, Ruzagira E. Predictors of loss to follow-up in an HIV vaccine preparedness study in Masaka, Uganda. Int J Environ Res Public Health. 2022;19:6377. doi: 10.3390/ijerph19116377
  • Weinhardt MS LS, Forsyth AD, Carey MP, Jaworski BC, Durant LE. Reliability and validity of self-report measures of HIV-related sexual behavior. Arch Sex Behav. 2008;27:155–180.